Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes

被引：0

作者：

Bourlon, Christianne ^{[1
]}

Roddie, Claire ^{[2
,3
]}

Menne, Tobias ^{[4
]}

Norman, Jane ^{[5
]}

O'Reilly, Maeve ^{[2
]}

Gibb, Adam ^{[6
]}

Besley, Caroline ^{[7
]}

Chaganti, Sridhar ^{[8
]}

Arias, Carlos Gonzalez ^{[9
]}

Jones, Ceri ^{[10
]}

Dikair, Abdalla ^{[11
]}

Allen, Sharon ^{[12
]}

Seymour, Frances ^{[13
]}

Osborne, Wendy ^{[4
]}

Mathew, Amrith ^{[8
]}

Townsend, William ^{[2
]}

Patten, Piers E. M. ^{[1
,14
]}

Thoulouli, Eleni ^{[5
]}

Abdulgawad, Ahmed ^{[15
]}

Lugthart, Sanne ^{[7
]}

Sanderson, Robin ^{[1
]}

Kirkwood, Amy A. ^{[16
]}

Kuhnl, Andrea ^{[1
]}

机构：

[1] Kings Coll Hosp London, Dept Hematol, London, England

[2] Univ Coll London Hosp, Dept Hematol, London, England

[3] UCL, UCL Canc Inst, London, England

[4] Newcastle Univ, Freeman Hosp, Dept Hematol, Newcastle, England

[5] Manchester Royal Infirm, Dept Hematol, Manchester, England

[6] Christie Hosp, Dept Med Oncol, Manchester, England

[7] Univ Hosp Bristol & Weston, Dept Hematol, Bristol, England

[8] Queen Elizabeth Hosp, Dept Hematol, Birmingham, England

[9] Royal Marsden Hosp, Dept Hematol, London, England

[10] Univ Hosp Wales, Dept Hematol, Cardiff, England

[11] Queen Elizabeth Hosp, Dept Hematol, Glasgow, Scotland

[12] Cambridge Univ Hosp, Dept Hematol, Cambridge, England

[13] Leeds Teaching Hosp, Dept Hematol, Leeds, England

[14] Kings Coll London, Comprehens Canc Ctr, London, England

[15] Christie Hosp, Dept Hematol, Manchester, England

[16] UCL, UCL Canc Inst, CR UK & UCL Canc Trials Ctr, London, England

来源：

HAEMATOLOGICA | 2024年 / 109卷 / 08期

关键词：

D O I：

10.3324/haematol.2024.285010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2716 / 2720

页数：5

共 50 条

[41] Complete responses to odronextamab in two patients with diffuse large B-cell lymphoma refractory to chimeric antigen receptor T-cell therapy
Weinstock, Matt
Elavalakanar, Pavania
Bright, Susan
Ambati, Srikanth R.
Brouwer-Visser, Jurriaan
Pourpe, Stephane
Fiaschi, Nathalie
Jankovic, Vladimir
Thurston, Gavin
Deering, Raquel P.
Chaudhry, Aafia
Joyce, Robin
Arnason, Jon
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (03) : 366 - 370
[42] Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell Therapy
Figura, Nicholas B.
Robinson, Timothy J.
Sim, Austin J.
Wang, Xuefeng
Cao, Biwei
Chavez, Julio C.
Shah, Bijal D.
Khimani, Farhad
Lazaryan, Aleksandr
Davila, Marco
Bachmeier, Christina
Nishihori, Taiga
Liu, Hien D.
Kim, Sungjune
Locke, Frederick L.
Jain, Michael D.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (05): : 1145 - 1154
[43] Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T-cell pathway in patients with diffuse large B-cell lymphoma
Lolli, Ginevra
Argnani, Lisa
Gini, Guido
Casadei, Beatrice
Pellegrini, Cinzia
Tani, Monica
Pavone, Vincenzo
Cimminiello, Michele
Bonifazi, Francesca
Zinzani, Pier Luigi
HEMATOLOGICAL ONCOLOGY, 2023, 41 (05) : 947 - 950
[44] Perceptions of Community Hematologists/Oncologists on Barriers to Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Diffuse Large B-Cell Lymphoma
Gajra, Ajeet
Sweat, Richard
Jeune-Smith, Yolaine
Kish, Jonathan K.
Feinberg, Bruce A.
BLOOD, 2019, 134
[45] Perceptions of community hematologists/oncologists on barriers to chimeric antigen receptor T-cell therapy for the treatment of diffuse large B-cell lymphoma
Gajra, Ajeet
Jeune-Smith, Yolaine
Kish, Jonathan
Yeh, Ting-Chun
Hime, Skyler
Feinberg, Bruce A.
IMMUNOTHERAPY, 2020, 12 (10) : 725 - 732
[46] Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma
Fried, Shalev
Shouval, Roni
Walji, Moneeza
Flynn, Jessica R.
Yerushalmi, Ronit
Shem-Tov, Noga
Danylesko, Ivetta
Tomas, Ana Alarcon
Fein, Joshua A.
Devlin, Sean M.
Sauter, Craig S.
Shah, Gunjan L.
Kedmi, Meirav
Jacoby, Elad
Shargian, Liat
Raanani, Pia
Yeshurun, Moshe
Perales, Miguel-Angel
Nagler, Arnon
Avigdor, Abraham
Shimoni, Avichai
TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (02): : 99 - 107
[47] Chidamide and sintilimab combination in diffuse large B-cell lymphoma progressing after chimeric antigen receptor T therapy
Hao, Yuan-Yuan
Chen, Pan-Pan
Yuan, Xiang-Gui
Zhao, Ai-Qi
Liang, Yun
Liu, Hui
Qian, Wen-Bin
WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (19) : 6555 - 6562
[48] Chimeric Antigen Receptor T Cells for B-Cell Lymphoma
Newcomb, Richard
Jacobson, Caron
CANCER JOURNAL, 2021, 27 (02): : 107 - 111
[49] Chidamide and sintilimab combination in diffuse large B-cell lymphoma progressing after chimeric antigen receptor T therapy
Yuan-Yuan Hao
Pan-Pan Chen
Xiang-Gui Yuan
Aiqi Zhao
Yun Liang
Hui Liu
Wen-Bin Qian
World Journal of Clinical Cases, 2022, (19) : 6555 - 6562
[50] Chylothorax after chimeric antigen receptor T cell therapy for relapsed and refractory diffuse large B-cell lymphoma: A case report
Chen, Hsin-Hui
Kuo, Cheng-Yi
Ho, Ching-Liang
Chen, Yeu-Chin
MEDICINE, 2023, 102 (41) : E35432

← 1 2 3 4 5 →